当前位置: 首页 > 期刊 > 《医学信息》 > 20202
编号:13516372
阿司匹林对高血压患者心血管疾病一级预防作用的Meta分析(4)
http://www.100md.com 2020年1月15日 《医学信息》 20202
     [12]Group ASC,Bowman L,Mafham M,et al.Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus[J].N Engl J Med,2018,379(16):1529-1539.

    [13]Peto R,Gray R,Collins R,et al.Randomised trial of prophylactic daily aspirin in British male doctors[J].Br Med J(Clin Res Ed),1988,296(618):313-316.

    [14]Frederick LF.Aspirin effects on mortality and morbidity in patients with diabetes mellitus.Early Treatment Diabetic Retinopathy Study report 14.ETDRS Investigators[J].JAMA,1992,268(10):1292-1300.

    [15]Ogawa H,Nakayama M,Morimoto T,et al.Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes:a randomized controlled trial[J].JAMA,2008,300(18):2134-2141.

    [16]Eikelboom JW,Connolly SJ,Bosch J,et al.Rivaroxaban with or without aspirin in stable cardiovascular disease[J].N Engl J Med,2017,377(14):1319-1330.

    [17]Bosch J,Eikelboom JW,Connolly SJ,et al.Rationale,design and baseline characteristics of participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies(COMPASS) trial[J].Can J Cardiol,2017,33(8):1027-1035.

    收稿日期:2019-11-13;修回日期:2019-12-16

    編辑/成森, 百拇医药(谢丽娟 黎冉 焦长青)
上一页1 2 3 4